Plasma kallikrein-IN-3

Modify Date: 2024-04-05 18:20:21

Plasma kallikrein-IN-3 structure	Common Name	Plasma kallikrein-IN-3
	CAS Number	1357950-47-0	Molecular Weight	365.43
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₀H₂₃N₅O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Plasma kallikrein-IN-3

Plasma kallikrein-IN-3 is a plasma kallikrein inhibitor (IC50: 0.15 μM). Plasma kallikrein-IN-3 can be used for hereditary angioedema, diabetic macular edema, and diabetic retinopathy research[1].

Name	Plasma kallikrein-IN-3

Description	Plasma kallikrein-IN-3 is a plasma kallikrein inhibitor (IC50: 0.15 μM). Plasma kallikrein-IN-3 can be used for hereditary angioedema, diabetic macular edema, and diabetic retinopathy research[1].
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Ser/Thr Protease Research Areas >> Cardiovascular Disease Research Areas >> Metabolic Disease
Target	Plasma kallikrein[1]
In Vitro	Plasma kallikrein-IN-3 (example 13, 1 nM-100 μM, 1 h) inhibits plasma kallikrein activity with an IC<>50 value of 0.15 μM[1].
References	[1]. Brandl Trixi, et al. Preparation of N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein. Patent WO2012017020.

Molecular Formula	C₂₀H₂₃N₅O₂
Molecular Weight	365.43